Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension

被引:295
作者
Hering, Dagmara [1 ,2 ]
Lambert, Elisabeth A. [1 ,5 ,6 ]
Marusic, Petra [1 ]
Walton, Antony S. [3 ]
Krum, Henry [3 ,4 ]
Lambert, Gavin W. [1 ,5 ,6 ]
Esler, Murray D. [1 ,3 ]
Schlaich, Markus P. [1 ,3 ,5 ,6 ]
机构
[1] Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis Lab, Melbourne, Vic 8008, Australia
[2] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[3] Alfred Hosp, Ctr Heart, Melbourne, Vic, Australia
[4] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[5] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia
[6] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
resistant hypertension; sympathetic nervous system; microneurography; single-unit; renal denervation; PATTERN; NORADRENALINE; DISCHARGE; SYSTEM; ASSOCIATION; WEIGHT;
D O I
10.1161/HYPERTENSIONAHA.111.00194
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Renal denervation (RDN) has been shown to reduce blood pressure (BP) and muscle sympathetic nerve activity (MSNA) in patients with resistant hypertension. The mechanisms underlying sympathetic neural inhibition are unknown. We examined whether RDN differentially influences the sympathetic discharge pattern of vasoconstrictor neurons in patients with resistant hypertension. Standardized office BP, single-unit MSNA, and multi-unit MSNA were obtained at baseline and at 3-month follow-up in 35 patients with resistant hypertension. Twenty-five patients underwent RDN, and 10 patients underwent repeated measurements without RDN (non-RDN). Baseline BP averaged 164/93 mm Hg (RDN) and 164/87 mm Hg (non-RDN) despite use of an average of 4.8 +/- 0.4 and 4.4 +/- 0.5 antihypertensive drugs, respectively. Mean office BP decreased significantly by -13/-6 mm Hg for systolic BP (P < 0.001) and diastolic BP (P < 0.05) with RDN but not in non-RDN at 3-month follow-up. RDN moderately decreased multi-unit MSNA (79 +/- 3 versus 73 +/- 4 bursts/100 heartbeats; P < 0.05), whereas all properties of single-unit MSNA including firing rates of individual vasoconstrictor fibers (43 +/- 5 versus 27 +/- 3 spikes/100 heartbeats; P < 0.01), firing probability (30 +/- 2 versus 22 +/- 2% per heartbeat; P < 0.02), and multiple firing incidence of single units within a cardiac cycle (8 +/- 1 versus 4 +/- 1% per heartbeat; P < 0.05) were substantially reduced at follow-up. BP, single-unit MSNA, and multi-unit MSNA remained unaltered in the non-RDN cohort at follow-up. RDN results in the substantial and rapid reduction in firing properties of single sympathetic vasoconstrictor fibers, this being more pronounced than multi-unit MSNA inhibition. Whether the earlier changes in single-unit firing patterns may predict long-term BP response to RDN warrants further exploration. (Hypertension. 2013;61:457-464.) circle Online Data Supplement
引用
收藏
页码:457 / +
页数:14
相关论文
共 36 条
[1]   ELEVATED SYMPATHETIC-NERVE ACTIVITY IN BORDERLINE HYPERTENSIVE HUMANS - EVIDENCE FROM DIRECT INTRANEURAL RECORDINGS [J].
ANDERSON, EA ;
SINKEY, CA ;
LAWTON, WJ ;
MARK, AL .
HYPERTENSION, 1989, 14 (02) :177-183
[2]  
[Anonymous], 2009, Global health risks: mortality and burden of disease attributable to selected major risks
[3]   Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension [J].
Burns, Joanna ;
Sivananthan, Mohan U. ;
Ball, Stephen G. ;
Mackintosh, Alan F. ;
Mary, David A. S. G. ;
Greenwood, John P. .
CIRCULATION, 2007, 115 (15) :1999-2005
[4]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[5]   The sympathetic nervous system and hypertension - Recent developments [J].
DiBona, GF .
HYPERTENSION, 2004, 43 (02) :147-150
[6]   OVERFLOW OF CATECHOLAMINE NEUROTRANSMITTERS TO THE CIRCULATION - SOURCE, FATE, AND FUNCTIONS [J].
ESLER, M ;
JENNINGS, G ;
LAMBERT, G ;
MEREDITH, I ;
HORNE, M ;
EISENHOFER, G .
PHYSIOLOGICAL REVIEWS, 1990, 70 (04) :963-985
[7]   Sympathetic nerve biology in essential hypertension [J].
Esler, M ;
Rumantir, M ;
Kaye, D ;
Jennings, G ;
Hastings, J ;
Socratous, F ;
Lambert, G .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (12) :986-989
[8]   MECHANISM OF ELEVATED PLASMA NORADRENALINE IN THE COURSE OF ESSENTIAL-HYPERTENSION [J].
ESLER, M ;
JENNINGS, G ;
BIVIANO, B ;
LAMBERT, G ;
HASKING, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S39-S43
[9]   REGIONAL NOREPINEPHRINE TURNOVER IN HUMAN HYPERTENSION [J].
ESLER, M ;
LAMBERT, G ;
JENNINGS, G .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1989, 11 :75-89
[10]   CENTRAL-NERVOUS-SYSTEM NORADRENERGIC CONTROL OF SYMPATHETIC OUTFLOW IN NORMOTENSIVE AND HYPERTENSIVE HUMANS [J].
ESLER, MD ;
LAMBERT, GW ;
FERRIER, C ;
KAYE, DM ;
WALLIN, BG ;
KALFF, V ;
KELLY, MJ ;
JENNINGS, GL .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1995, 17 (1-2) :409-423